Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02697227 · ClinicalTrials.gov registry record · NA
Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation
A NA study of Tobacco Use Disorder and Cigarette Smoker, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 85
- Enrollment target
- 1
- Study location
NCT02697227: Active NA study of Tobacco Use Disorder and Cigarette Smoker, sponsored by M.D. Anderson Cancer Center.
NCT02697227 is a NA study of Tobacco Use Disorder and Cigarette Smoker that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 85 participants, below the 238-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02697227, a NA study of Tobacco Use Disorder and Cigarette Smoker, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized clinical trial studies how well behavioral activation therapy and nicotine replacement therapy work in increasing smoking cessation. Behavioral interventions use techniques to help patients change the way they react to environmental triggers that may cause a negative reaction. Giving behavioral activation therapy and nicotine replacement therapy may help patients quit smoking or change their smoking behavior.
Conditions Studied
Interventions
- OTHER Laboratory Biomarker Analysis
- BEHAVIORAL Smoking Cessation Intervention
- OTHER Questionnaire Administration
- BEHAVIORAL Behavioral Intervention
- DRUG Nicotine Patch
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2016-08-05 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What the registry record for NCT02697227 still lists
NCT02697227 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 238-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (64% lower).
The record links to 2 conditions, with Tobacco Use Disorder appearing as the primary indexed condition, and to 5 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT02697227 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02697227 about?
NCT02697227 is a clinical study titled "Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation". This randomized clinical trial studies how well behavioral activation therapy and nicotine replacement therapy work in increasing smoking cessation. Behavioral interventions use techniques to help patients change the way they react to environmental triggers that may cause a negative reaction. Giving...
What is the current status of trial NCT02697227?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 85 participants. The study started on 2016-08-05. Estimated completion is 2027-12-31.
What conditions does trial NCT02697227 study?
This clinical trial studies the following conditions: Tobacco Use Disorder, Cigarette Smoker.
What interventions are being tested in trial NCT02697227?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Smoking Cessation Intervention (BEHAVIORAL), Questionnaire Administration (OTHER), Behavioral Intervention (BEHAVIORAL), Nicotine Patch (DRUG).
Who is sponsoring clinical trial NCT02697227?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02697227 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02697227's enrollment target sits among peer trials
85 41st of 70 higher than 30 of 70 other Tobacco Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smoking Cessation CM for Veterans With or at Risk for Cancer
RECRUITING · NA
-
Smoking Cessation Behavioral Treatment Study
RECRUITING · NA
-
Contingency Management for Veteran Smokers Undergoing Major Elective Surgery
RECRUITING · NA
-
A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder
RECRUITING · NA
-
Young Adult Tobacco/Nicotine and Cannabis Co-use
RECRUITING · NA
-
Low Intensity Focused Ultrasound for Tobacco Use Disorder: High Resolution Targeting of the Human Insula
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI